Sudo Biosciences Email Format
Biotechnology ResearchIndiana, United States11-50 Employees
Sudo Biosciences is a biotechnology research company based in Carmel, Indiana. Its work centers on designing and developing novel, precision medicines with lead programs targeting the TYK2 pseudokinase domain to influence cytokine signaling. These TYK2-focused programs are aimed at treating immune-mediated inflammatory conditions. Its target market encompasses the biopharmaceutical industry pursuing therapies for immune-mediated inflammatory diseases. In December 2025, Sudo Biosciences announced the appointment of Paul S. Bavier as Chief Legal Officer.